| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Australia | 2 | |
| #3 | Canada | 2 | |
| #4 | China | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Israel | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 2 | |
| #9 | Colombia | 1 | |
| #10 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Blumberg Richard S | 18 |
| #2 | Blumberg Laurence J | 18 |
| #3 | Roopenian Derry | 18 |
| #4 | Holgate Robert George Edward | 17 |
| #5 | Hearn Arron Robert | 17 |
| #6 | Jones Timothy David | 17 |
| #7 | Jones Susan Dana | 15 |
| #8 | Jones Susan D | 3 |
| #9 | Jones Timothy D | 1 |
| #10 | Holgate Robert George E | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2017257680A1 | Humanized affinity matured anti-FcRn antibodies | |
| AU2016262100A1 | Humanized affinity matured anti-FcRn antibodies |